Cargando…

Integrated Analysis and Identification of Novel Biomarkers in Parkinson’s Disease

Parkinson’s disease (PD) is a quite common neurodegenerative disorder with a prevalence of approximately 1:800–1,000 in subjects over 60 years old. The aim of our study was to determine the candidate target genes in PD through meta-analysis of multiple gene expression arrays datasets and to further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Jieshan, Xie, Qizhi, Jia, Jingjing, Liu, Xiaoma, Sun, Jingjing, Deng, Yuanfei, Yi, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016006/ https://www.ncbi.nlm.nih.gov/pubmed/29967579 http://dx.doi.org/10.3389/fnagi.2018.00178

Ejemplares similares

Prognostic Value of Albumin/Globulin Ratio in Survival and Lymph Node Metastasis in Patients with Cancer: A Systematic Review and Meta-analysis
por: Chi, Jieshan, et al.
Publicado: (2018)

Identification of novel biomarkers in ischemic stroke: a genome-wide integrated analysis
por: Xie, Qizhi, et al.
Publicado: (2020)

Integrated analysis and identification of hub genes as novel biomarkers for Alzheimer’s disease
por: Zhao, Kun, et al.
Publicado: (2022)

Recent Advances in Biomarkers for Parkinson’s Disease
por: He, Runcheng, et al.
Publicado: (2018)

Novel diagnostic biomarkers related to immune infiltration in Parkinson’s disease by bioinformatics analysis
por: Zhang, Pengfei, et al.
Publicado: (2023)

Identification of necroptosis-related genes in Parkinson’s disease by integrated bioinformatics analysis and experimental validation
por: Lei, Cheng, et al.
Publicado: (2023)

Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression
por: Dong, Mei-Xue, et al.
Publicado: (2018)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
por: Liu, Yumei, et al.
Publicado: (2022)

Identification of hub genes of Parkinson's disease through bioinformatics analysis
por: Yang, Yajun, et al.
Publicado: (2022)

Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
por: Lin, Chin-Hsien, et al.
Publicado: (2018)

Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
por: Santiago, Jose A., et al.
Publicado: (2018)

Editorial: Integrative Approach to Parkinson's Disease
por: Kim, Seung-Nam, et al.
Publicado: (2019)

Identification of diagnostic biomarkers in Alzheimer’s disease by integrated bioinformatic analysis and machine learning strategies
por: Jin, Boru, et al.
Publicado: (2023)

Parkinson’s Disease: Biomarkers, Treatment, and Risk Factors
por: Emamzadeh, Fatemeh N., et al.
Publicado: (2018)

Biomarkers and the Role of α-Synuclein in Parkinson’s Disease
por: Du, Tingting, et al.
Publicado: (2021)

Identifying crosstalk genetic biomarkers linking a neurodegenerative disease, Parkinson’s disease, and periodontitis using integrated bioinformatics analyses
por: Hu, Shaonan, et al.
Publicado: (2022)

Effectiveness of Integrative Therapy for Parkinson’s Disease Management
por: Woo, Yeonju, et al.
Publicado: (2019)

Autistic Spectrum Disorder Detection and Structural Biomarker Identification Using Self-Attention Model and Individual-Level Morphological Covariance Brain Networks
por: Wang, Zhengning, et al.
Publicado: (2021)

Genetic Analysis and Literature Review of SNCA Variants in Parkinson's Disease
por: Guo, Yi, et al.
Publicado: (2021)

Identification of novel immune-related biomarker and therapeutic drugs in Parkinson disease via integrated bioinformatics analysis
por: Yang, Xiaoxia, et al.
Publicado: (2023)

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
por: Roser, Anna Elisa, et al.
Publicado: (2018)

Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease
por: Lin, Yuwan, et al.
Publicado: (2021)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Identification and Characterization of Biomarkers and Their Role in Opioid Addiction by Integrated Bioinformatics Analysis
por: Zhang, Xiuning, et al.
Publicado: (2020)

Identification of BAG5 as a Potential Biomarker for Parkinson’s Disease Patients With R492X PINK1 Mutation
por: Fu, Yu, et al.
Publicado: (2022)

Identification of biomarkers differentiating Alzheimer’s disease from other neurodegenerative diseases by integrated bioinformatic analysis and machine-learning strategies
por: Jin, Boru, et al.
Publicado: (2023)

Identification and quantitative assessment of motor complications in Parkinson’s disease using the Parkinson’s KinetiGraph™
por: Qu, Yan, et al.
Publicado: (2023)

Emerging Role of Sirtuin 2 in Parkinson’s Disease
por: Liu, Yumei, et al.
Publicado: (2020)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Quantitative Electroencephalography as a Biomarker for Cognitive Dysfunction in Parkinson’s Disease
por: Novak, Kevin, et al.
Publicado: (2022)

The associations of cerebrospinal fluid biomarkers with cognition, and rapid eye movement sleep behavior disorder in early Parkinson’s disease
por: Tao, Mingzhu, et al.
Publicado: (2022)

Structural Covariance Network Disruption and Functional Compensation in Parkinson’s Disease
por: Zhou, Cheng, et al.
Publicado: (2020)

Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus
por: Sun, Jingjing, et al.
Publicado: (2019)

Integrated Genetic Analysis of Racial Differences of Common GBA Variants in Parkinson's Disease: A Meta-Analysis
por: Zhang, Yuan, et al.
Publicado: (2018)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)

Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
por: Lucio, Marianna, et al.
Publicado: (2019)

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
por: Ganguly, Upasana, et al.
Publicado: (2021)

Proteomics Challenges for the Assessment of Synuclein Proteoforms as Clinical Biomarkers in Parkinson’s Disease
por: Pons, Marie-Laure, et al.
Publicado: (2022)

Monogenetic Forms of Parkinson’s Disease – Bridging the Gap Between Genetics and Biomarkers
por: Tönges, Lars, et al.
Publicado: (2022)

The Potential Circular RNAs Biomarker Panel and Regulatory Networks of Parkinson’s Disease
por: Xiao, Yousheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n5okjpc4pl46k1m0pl5ssdl382